SCHEMBL2934798

SCHEMBL2934798

C[C@@H](NC(=O)O)c1cccc2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.61
GAA P10253 1/20 0.61
EPHX2 P34913 2/20 0.59
SSTR4 P31391 1/20 0.58
PDE2A O00408 1/20 0.56
LTC4S Q16873 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
METAP2 P50579 1/20 0.55
METAP1 P53582 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263715 1.00 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL8518963 1.00 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
Trifluoroacetic Acid SCHEMBL3338958 0.91 HDAC3 (0.60) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL24575927 0.88 EPHX2 (0.64) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL6529748 0.86 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL9817975 0.86 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL1567110 0.86 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL29609692 0.86 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL6514206 0.86 LMNA (0.61) LMNAGAAEPHX2SSTR4PDE2A
SCHEMBL14484271 0.85 LMNA (0.64) LMNAGAAEPHX2PDE2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4276230-A Cyano-3-phenoxybenzyl N-1-(1-naphthyl) ethylcarbamate ZOECON CORPORATION (US) 1981-06-30 US claimed
US-20150038546-A1 SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS LUPIN LIMITED (IN) 2015-02-05 US disclosed
EP-2374802-B1 KYNURENINE PRODUCTION INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2014-04-23 EP disclosed
EP-1836163-B1 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN NOVARTIS AG (CH) 2010-09-22 EP disclosed
US-20100087427-A1 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN BREITENSTEIN WERNER 2010-04-08 US disclosed
EP-0038617-B1 DIASTEREOMERS OF AMINO ACID ESTERS, PESTICIDAL COMPOSITIONS INCLUDING THEM AND METHOD OF CONTROLLING PESTS USING THEM ZOECON CORPORATION (US) 1983-07-20 EP disclosed
EP-0038617-A1 Diastereomers of amino acid esters, pesticidal compositions including them and method of controlling pests using them ZOECON CORPORATION (US) 1981-10-28 EP disclosed
US-4276230-A Cyano-3-phenoxybenzyl N-1-(1-naphthyl) ethylcarbamate ZOECON CORPORATION (US) 1981-06-30 US disclosed
US-4260633-A INSECTICIDES, MITICIDES ZOECON CORPORATION (US) 1981-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087427-A1 PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE DEPENDING ON THE ACTIVITY OF RENIN REN, ACE, PEPD LMNA 2796/4885GAA 84/4885EPHX2 1119/4885
US-20150038546-A1 SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS CASR, RYR2, CALCR LMNA 1922/4885GAA 1174/4885EPHX2 4073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.